
Lymphomatoid Granulomatosis - 10 Studies Found
Completed |
: Treatment and Natural History Study of Lymphomatoid Granulomatosis :
: 1999-11-03 : |
Recruiting |
: Tissue Collection for Studies of Lymph Cancer :
|
Completed |
: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma :
|
Completed |
: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma :
|
Completed |
: Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction :
|
Terminated |
: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma : : 2025-08-02 |
Terminated |
: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas :
|
Completed |
: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction :
|
Terminated |
: Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma :
|
COMPLETED |
: Treatment and Natural History Study of Lymphomatoid Granulomatosis : Lymphomatoid Granulomatosis : 2025-08-02 : For LYG Grade 1 and 2: Interferon starting at 7.5 million Units subQ 3 times a week and increasing on the following schedule: 10 million U; 15 million |